Table 1 Baseline characteristics
Characteristics | Before matching (N = 1139) | After matching (N = 348) | ||||
|---|---|---|---|---|---|---|
No rebleeding (N = 648) | Rebleeding (N = 491) | SD | No rebleeding (N = 192) | Rebleeding (N = 156) | SD | |
Age (yr) | 50.7 ± 10.3 | 51.8 ± 10.4 | −1.168 | 51.8 ± 10.6 | 51.8 ± 11.5 | −0.019 |
Male sex | 483 (74.5%) | 364 (74.1%) | 0.024 | 123 (64.1%) | 98 (62.8%) | 0.057 |
Antiviral therapy | 549 (84.7%) | 374 (76.2%) | 13.291 | 109 (56.8%) | 65 (41.7%) | 7.854 |
Diabetes | 117 (18.1%) | 140 (28.5%) | 17.484 | 19 (9.9%) | 35 (22.4%) | 10.324 |
Alcohol consumption | 18 (2.8%) | 16 (3.3%) | 0.223 | 2 (1.0%) | 3 (1.9%) | 0.472 |
Ascites | 479 (73.9%) | 419 (85.3%) | 21.824 | 142 (74.0%) | 136 (87.2%) | 9.363 |
WBC (× 109/L) | 4.0 (2.7, 6.4) | 4.3 (3.0, 6.2) | −0.036 | 4.5 (3.0, 7.5) | 4.8 (3.3, 7.0) | 0.268 |
PLT (×109/L) | 62.0 (44.4, 89.0) | 66.9 (46.4, 94.0) | −5.554 | 66.0 (44.4, 97.8) | 73.5 (52.5, 111.8) | −6.968 |
HGB (g/l) | 89.2 ± 25.2 | 84.1 ± 25.4 | 5.075 | 81.2 (67.4, 101.0) | 77.7 (60.2, 93.2) | 5.946 |
ALT (U/L) | 23.1 (17.1, 32.8) | 22.5 (17.0, 33.0) | −3.724 | 22.2 (17.0, 32.6) | 21.7 (16.2, 33.0) | −4.208 |
AST (U/L) | 28.6 (21.7, 39.7) | 29.0 (22.4, 41.0) | −10.332 | 27.5 (21.6, 39.8) | 28.9 (22.4, 39.5) | −13.064 |
TBIL (μmol/l) | 17.9 (12.8, 25.3) | 18.1 (11.9, 25.1) | −2.604 | 16.7 (11.9, 23.8) | 17.1 (10.9, 24.4) | −5.402 |
GGT (U/L) | 19.2 (12.9, 31.2) | 26.4 (15.6, 45.3) | −14.324 | 20.1 (12.4, 33.5) | 26.9 (14.1, 43.5) | −15.883 |
ALB (g/l) | 33.1 ± 5.8 | 32.7 ± 5.7 | 0.383 | 31.9 ± 5.4 | 31.8 ± 5.7 | 0.163 |
Cr (μmol/l) | 63.3 (53.7, 74.3) | 63.9 (53.4, 75.8) | −0.539 | 58.9 (48.6, 69.4) | 59.4 (48.9, 72.3) | −1.935 |
PT (s) | 14.9 (13.9, 16.2) | 15.0 (13.7, 16.4) | −0.076 | 15.0 (14.0, 16.5) | 15.3 (14.2, 16.8) | −0.516 |
AFP (ng/ml) | 2.8 (1.8, 5.3) | 3.1 (1.7, 5.9) | −1.990 | 2.8 (1.8, 5.3) | 3.3 (1.7, 5.9) | −0.955 |
HBeAg (positive) | 146 (26.9%) | 103 (25.6%) | 0.211 | 21 (10.9%) | 21 (13.5%) | −0.025 |
HBV-DNA (positive) | 128 (30.3%) | 86 (29.2%) | 0.102 | 34 (26.0%) | 26 (28.0%) | 0.111 |
MELD score | 6.1 ± 4.2 | 6.3 ± 4.9 | −0.194 | 4.8 ± 4.8 | 5.7 ± 5.4 | −0.881 |
CTP class (A/B/C) | 177/359/112 | 81/296/114 | 20.548 | 44/113/35 | 20/95/41 | 7.386 |